CX3CR1 and Sepsis: The immunoreactivity of both molecules was tested on lung samples obtained from 8 non-sepsis control cases and 9 sepsis cases: both CCR2+ and CX3CR1+ mononuclear cells were significantly higher in the sepsis group compared to controls (p < 0.01).